Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing — Stella

View on ClinicalTrials.gov

Recruiting

Back to Uveitis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of California San Francisco (UCSF), San Francisco, California

Key details

Sponsor

University of California, San Francisco

Collaborators

University of Nebraska, University of Utah

Enrollment target

~100 participants

Started

June 2022

Primary completion

December 2026

Age range

18 Years and older

Last updated July 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.